Disruption of Cav1.2-mediated signaling is a pathway for ketamine-induced pathology.
Chen, Huan, David H Vandorpe, Xiang Xie, Seth L Alper, Mark L Zeidel, and Weiqun Yu. 2020. “Disruption of Cav1.2-Mediated Signaling Is a Pathway for Ketamine-Induced Pathology.”. Nature Communications 11 (1): 4328.